One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says

One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says

Source: 
Fierce Pharma
snippet: 

Pharma companies are a popular target for politicians, activists and critics in general. But with the world in dire need of COVID-19 drugs and vaccines, the industry has a rare chance to bolster its image, Eli Lilly CEO Dave Ricks said Thursday.